HCAT Stock Forecast & Price Target

Health Catalyst is a healthcare data and analytics company with a strong technology segment that includes a cloud-based subscription model. While the recent divestiture of Vitalware may lead to a slight decrease in profitability in the short term, the company's strong proforma cash position and focus on high-conviction opportunities for transformation indicate a potential for long-term growth. Additionally, the company's introduction of new bookings as a metric and strong Q1 bookings suggest positive momentum and the potential for cost savings through Project Nexus adds another lever for future profitability.

Health Catalyst is facing significant challenges, including the completion of vital divestitures and a decline in revenue and EBITDA guidance for the fiscal year. Additionally, the company is experiencing churn and migration pressure in its customer base, with uncertainties about its ability to stabilize the business and return to profitable growth. The company also faces risks from a challenging end market and negative mix shift in its business segments. With these challenges, it is recommended to hold Health Catalyst's stock and wait for further proof of its ability to grow profitably.